Faceless assessment causes delay in customs clearance Usha Sharma Oct 15, 2020 Industry urges government to waive off demurrage charges
Lactiga and Mount Sinai sign pact to advance its patented biologic for COVID-19 treatment EP News Bureau Oct 14, 2020 The collaborative team secured an NIH R01 Emergency Award of $2 million dollars to expand this study
COVID-19 has made online learning a credible source of education Lakshmipriya Nair Oct 14, 2020 Romola Pinto, who leads the Rubicon Academy team and also heads the HR function at Rubicon Research, speaks about the…
Eli Lilly pauses trial of antibody drug for COVID-19 over safety concern Reuters Oct 14, 2020 The company had said earlier this month that it was applying for EUA for the antibody-drug, LY-CoV555, for patients with mild to…
TSHA-102 from Taysha gets rare paediatric disease and orphan drug designations for Rett syndrome EP News Bureau Oct 14, 2020 Taysha anticipates that it will submit an Investigational New Drug (IND) application for TSHA-102 to the FDA in 2021
$12 bn fresh funding from World Bank for COVID-19 vaccines, treatments in developing countries Reuters Oct 14, 2020 $12 bn fresh funding from World Bank for COVID-19 vaccines, treatments in developing countries
HMD supplies first lot of 56 mn syringes to Covax facility EP News Bureau Oct 14, 2020 Covax facility has ordered 140 million KOJAK AD Syringes from HMD to be supplied between August and December 2020
Glenmark launches NINDANIB (nintedanib) for pulmonary fibrosis in India EP News Bureau Oct 14, 2020 Two clinical trials are being rolled out to study the efficacy and safety of Nintedanib as a treatment of SARS-COV2 induced…
SPARC announces Phase 3 trial results of SDN-037 to treat inflammation and pain of ocular surgery EP News Bureau Oct 14, 2020 The primary efficacy measure was the proportion of subjects with an anterior chamber cell (ACC) grade of zero (0) on Day 15 (zero…
SEC asks CDSCO to submit adverse event report of death during Umifenovir trial Usha Sharma Oct 14, 2020 It should include analysis of the ethics committee, investigator and sponsor etc., for review